Stockholders’ Deficit (Tables)

12 Months Ended

Dec. 31, 2021

Stockholders' Equity Note [Abstract]

Schedule of stock options

	Shares			Weighted Average Exercise Price		Weighted Average Contractual Term Outstanding		Intrinsic Value
Outstanding at January 1, 2020		32,900,000			0.1428		6.6	$	4,731,000
Granted		-			-
Exercised		(900,000	)		0.0700
Forfeited or expired		-			-
Outstanding at December 31, 2020		32,000,000		$	0.1419		5.6	$	6,054,000
Granted		1,915,000		$	0.7806
Exercised		(4,500,000	)	$	0.0856
Forfeited or expired		(1,000,000	)	$	0.3700
Outstanding at December 31, 2021		28,415,000		$	0.1859		5.84	$	60,640,900
Outstanding and exercisable at December 31, 2021		23,128,888		$	0.1291		5.84	$	50,673,665

Schedule of black-scholes- merton option-pricing model applying the assumptions

	For the year ended December 31,
	2021			2020
Expected life (years)		2-3			N/A
Dividend yield		0	%		N/A
Expected volatility		128-130	%		N/A
Risk free interest rates		.05-.07			N/A

	For the year ended December 31,
	2021		2020
Expected life (years)		N/A		1.0
Dividend yield		N/A		0	%
Expected volatility		N/A		125.19	%
Risk free interest rates		N/A		0.14	%
Weighted average fair value of warrants at grant date	$	N/A		.308

Schedule of fair value of restricted stock and restricted stock units

	Restricted Stock Outstanding
	Shares		Weighted Average Fair Value per Share at Grant Date
Outstanding at December 31, 2019		-
Granted – restricted stock units and awards		75.000		0.35
Granted – performance based stock units		-		-
Canceled		-		-
Vested and converted to shares		-		-
Outstanding at December 31, 2020		75,000		0.35
Granted – restricted stock units and awards		140,000		0.61
Granted – performance based stock units		-
Canceled		-
Vested and converted to shares		-
Outstanding at December 31, 2021		215,000		0.52

Schedule of unrecognized stock-based compensation related to unvested restricted stock, net of estimated forfeitures

	Warrant Activity
	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)
Outstanding at January 1, 2020		3,675,000		$	0.0632		6.96
Granted		50,000			0.0500
Exercised		(175,000	)		0.0700
Forfeited or expired		-			-
Outstanding at December 31, 2020		3,550,000		$	0.0627		6.17
Granted		-			-		-
Exercised		(1,650,000	)		0.0652
Forfeited or expired		(125,000	)		0.0599
Outstanding at December 31, 2021		1,775,000		$	0.0599		7.43
Outstanding and exercisable at December 31, 2021		1,775,000			0.0599		7.43

Schedule of range exercise prices warrants outstanding and exercisable

	Warrants Outstanding						Warrants Exercisable
			Weighted Avg.
			Remaining
	Shares		Contractual		Weighted Avg.		Shares		Weighted Avg.
Range of Exercise Prices	Outstanding		Life in Years		Exercise Price		Exercisable		Exercise Price
$0.05 - $0.07		1,775,000		7.43	$	0.0599		1,775,000	$	0.0599
		1,775,000		7.43	$	0.0599		1,775,000	$	0.0599